Dive into our NephU resources! This infographic reviews just part of the reason why racial and ethnic diversity is important to kidney disease clinical trials. Read More
La poliquistosis renal autosómica dominante, o ADPKD por sus siglas en inglés, representa la mayor parte de los casosde riñón poliquístico (9 de 10). Algunas personas con ADPKD están en… Read More
Hablar sobre la ADPKD es una decisión personal y puede ser difícil para su ser querido que enfrenta esta afección. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.